INMD on Nasdaq
InMode Ltd.
Electromedical and electrotherapeutic apparatus company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with TransMedics Group, Inc., Axogen, Inc. or Zynex, or pick any stock.
- TickerINMD on Nasdaq1
- IndustryElectromedical & Electrotherapeutic Apparatus1
- HeadquartersL31
- Incorporated inIsrael3
- Business addressTavor Building, Sha?Ar Yokneam, Pob 533, Yokneam, L3 20692003
- Filer categoryLarge accelerated filer3
See how the biggest companies compare on our leaderboards
RF energy depends on the distance between the two electrodes on the probe, with increasing distance resulting in increased depth of penetration.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Capital Equipment brought in 78% of the revenue InMode Ltd. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capital Equipment | $412.1M | $315.5M | $289.1M |
| Consumables And Service Revenues | $80.0M | $79.3M | $81.4M |
Regions
United States brought in 54% of the revenue InMode Ltd. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $307.8M | $244.8M | $198.7M |
| Europe | $62.5M | $63.4M | $79.0M |
| Asia | $47.7M | $43.0M | $49.2M |
| Other Country | $71.1M | $39.9M | $40.2M |
| Israel | $2.9M | $3.7M | $3.4M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue21¢$79.5M
- Research and development4¢$13.3M
- Other costs45¢$167.3M
- Income tax4¢$16.5M
- Profit25¢$93.8M
Out of $370.5M in revenue.2
Where each dollar of operating cash went, fiscal 2025
- Capital spending1¢$972.0K
- Share buybacks99¢$127.4M
Out of $85.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.2
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| REVENUES | $370.5M | $394.8M | $492.0M |
| COST OF REVENUES | $79.5M | $77.8M | $80.7M |
| GROSS PROFIT | $291.0M | $317.1M | $411.3M |
| Research and development | $13.3M | $13.1M | $13.4M |
| Sales and marketing | $180.6M | $181.4M | $193.0M |
| General and administrative | $11.7M | $10.0M | $9.2M |
| TOTAL OPERATING EXPENSES | $205.6M | $204.5M | $215.7M |
| OPERATING INCOME | $85.4M | $112.5M | $195.7M |
| Finance income, net | $24.9M | $30.9M | $21.6M |
| INCOME BEFORE INCOME TAXES | $110.3M | $143.5M | $217.3M |
| INCOME TAXES BENEFIT (EXPENSES) | -$16.5M | $37.8M | -$19.3M |
| NET INCOME | $93.8M | $181.3M | $197.9M |
| Basic | $1.45 | $2.29 | $2.37 |
| Diluted | $1.43 | $2.25 | $2.30 |
| Basic | 64.6M shares | 79.3M shares | 83.5M shares |
| Diluted | 65.4M shares | 80.6M shares | 86.0M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 2 fiscal years (annual) or 2 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $302.5M | $155.3M |
| Marketable securities (amortized cost of $83,542 and $268,129, as of December 31, 2025 and 2024, respectively) | $83.6M | $267.7M |
| Short-term bank deposits | $169.2M | $173.5M |
| Accounts receivable, net of allowance for credit losses of $2,371 and $1,825, as of December 31, 2025, and 2024, respectively | $43.5M | $36.3M |
| Prepaid expenses and other receivables | $25.7M | $22.1M |
| Inventories | $74.0M | $59.5M |
| TOTAL CURRENT ASSETS | $698.6M | $714.5M |
| Accounts receivable net of allowance for credit losses of $856 and $924 as of December 31, 2025, and 2024, respectively | $3.0M | $3.2M |
| Deferred income tax assets | $53.2M | $56.3M |
| Operating lease right-of-use assets | $8.3M | $8.7M |
| Property and equipment, net | $2.6M | $2.3M |
| Other investments | $700.0K | $700.0K |
| TOTAL NON-CURRENT ASSETS | $67.8M | $71.2M |
| TOTAL ASSETS | $766.4M | $785.7M |
| Accounts payables | $17.9M | $13.8M |
| Contract liabilities | $12.1M | $16.8M |
| Other liabilities | $40.7M | $39.3M |
| TOTAL CURRENT LIABILITIES | $70.7M | $69.9M |
| Contract liabilities | $3.0M | $3.3M |
| Other liabilities | $4.4M | $3.4M |
| Operating lease liabilities | $5.0M | $5.3M |
| TOTAL NON-CURRENT LIABILITIES | $12.5M | $12.0M |
| TOTAL LIABILITIES | $83.2M | $81.9M |
| Ordinary shares, NIS 0.01 par value, authorized 200,000,000 shares at December 31, 2025, and 2024 Issued 88,333,753 and 87,583,673 shares at December 31, 2025 and 2024, respectively Outstanding 63,358,750 and 69,558,670 shares at December 31, 2025 and 2024, respectively | $251.0K | $249.0K |
| Additional paid-in capital | $209.6M | $197.0M |
| Retained earnings | $968.5M | $874.7M |
| Accumulated other comprehensive loss | $69.0K | -$340.0K |
| Less treasury shares, at cost: 24,975,003 and 18,025,003 ordinary shares at December 31, 2025 and 2024, respectively | -$495.3M | -$367.8M |
| TOTAL SHAREHOLDERS EQUITY | $683.2M | $703.8M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $766.4M | $785.7M |
| Marketable securities, net of amortization | $83.5M | $268.1M |
| Accounts receivable allowance for credit loss | $2.4M | $1.8M |
| Accounts receivable allowance for credit loss | $856.0K | $924.0K |
| Ordinary shares, shares authorized | 200.0M shares | 200.0M shares |
| Ordinary shares, issued shares | 88.3M shares | 87.6M shares |
| Ordinary shares, outstanding shares | 63.4M shares | 69.6M shares |
| Treasury shares, ordinary shares | 25.0M shares | 18.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $302.5M | $155.3M |
| Marketable securities (amortized cost of $83,542 and $268,129, as of December 31, 2025 and 2024, respectively) | $83.6M | $267.7M |
| Short-term bank deposits | $169.2M | $173.5M |
| Accounts receivable, net of allowance for credit losses of $2,371 and $1,825, as of December 31, 2025, and 2024, respectively | $43.5M | $36.3M |
| Prepaid expenses and other receivables | $25.7M | $22.1M |
| Inventories | $74.0M | $59.5M |
| TOTAL CURRENT ASSETS | $698.6M | $714.5M |
| Accounts receivable net of allowance for credit losses of $856 and $924 as of December 31, 2025, and 2024, respectively | $3.0M | $3.2M |
| Deferred income tax assets | $53.2M | $56.3M |
| Operating lease right-of-use assets | $8.3M | $8.7M |
| Property and equipment, net | $2.6M | $2.3M |
| Other investments | $700.0K | $700.0K |
| TOTAL NON-CURRENT ASSETS | $67.8M | $71.2M |
| TOTAL ASSETS | $766.4M | $785.7M |
| Accounts payables | $17.9M | $13.8M |
| Contract liabilities | $12.1M | $16.8M |
| Other liabilities | $40.7M | $39.3M |
| TOTAL CURRENT LIABILITIES | $70.7M | $69.9M |
| Contract liabilities | $3.0M | $3.3M |
| Other liabilities | $4.4M | $3.4M |
| Operating lease liabilities | $5.0M | $5.3M |
| TOTAL NON-CURRENT LIABILITIES | $12.5M | $12.0M |
| TOTAL LIABILITIES | $83.2M | $81.9M |
| Ordinary shares, NIS 0.01 par value, authorized 200,000,000 shares at December 31, 2025, and 2024 Issued 88,333,753 and 87,583,673 shares at December 31, 2025 and 2024, respectively Outstanding 63,358,750 and 69,558,670 shares at December 31, 2025 and 2024, respectively | $251.0K | $249.0K |
| Additional paid-in capital | $209.6M | $197.0M |
| Retained earnings | $968.5M | $874.7M |
| Accumulated other comprehensive loss | $69.0K | -$340.0K |
| Less treasury shares, at cost: 24,975,003 and 18,025,003 ordinary shares at December 31, 2025 and 2024, respectively | -$495.3M | -$367.8M |
| TOTAL SHAREHOLDERS EQUITY | $683.2M | $703.8M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $766.4M | $785.7M |
| Marketable securities, net of amortization | $83.5M | $268.1M |
| Accounts receivable allowance for credit loss | $2.4M | $1.8M |
| Accounts receivable allowance for credit loss | $856.0K | $924.0K |
| Ordinary shares, shares authorized | 200.0M shares | 200.0M shares |
| Ordinary shares, issued shares | 88.3M shares | 87.6M shares |
| Ordinary shares, outstanding shares | 63.4M shares | 69.6M shares |
| Treasury shares, ordinary shares | 25.0M shares | 18.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $93.8M | $181.3M | $197.9M |
| Depreciation | $695.0K | $728.0K | $623.0K |
| Share-based compensation expenses | $11.1M | $16.6M | $23.6M |
| Change in allowance for credit losses of trade receivable | $454.0K | $572.0K | $1.0M |
| Loss on marketable securities, net | $15.0K | $167.0K | $0 |
| Finance expenses (income), net | $498.0K | -$4.4M | -$4.7M |
| Deferred income tax assets, net | $2.9M | -$55.2M | -$184.0K |
| Decrease (increase) in accounts receivable (including non-current) | -$7.5M | $5.9M | -$16.1M |
| Increase in other receivables | -$3.7M | -$5.7M | -$2.2M |
| Increase in inventories | -$14.5M | -$14.5M | -$5.2M |
| Increase (decrease) in accounts payable | $4.1M | -$184.0K | -$2.3M |
| Increase (decrease) in other liabilities (including non-current) | $2.2M | $1.9M | -$12.6M |
| Increase (decrease) in contract liabilities (including non-current) | -$5.0M | $5.4M | -$3.1M |
| Net cash provided by operating activities | $85.3M | $132.7M | $176.8M |
| Investment in short-term deposits | -$292.6M | -$168.2M | -$233.2M |
| Proceeds from short-term deposits | $293.1M | $218.7M | $85.1M |
| Purchase of fixed assets | -$972.0K | -$669.0K | -$705.0K |
| Other investments | $0 | $0 | -$100.0K |
| Purchase of marketable securities | -$20.9M | -$336.2M | -$245.3M |
| Proceeds from sale of marketable securities | $17.2M | $90.8M | $5.0M |
| Proceeds from maturity of marketable securities | $190.2M | $357.8M | $253.2M |
| Net cash provided by (used in) investing activities | $186.0M | $162.2M | -$136.1M |
| Repurchase of ordinary shares | -$127.4M | -$285.4M | $0 |
| Exercise of options | $1.4M | $2.6M | $5.5M |
| Net cash provided by (used in) financing activities | -$126.1M | -$282.8M | $5.5M |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | $2.0M | -$1.2M | $605.0K |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | $147.2M | $10.9M | $46.9M |
| Income taxes paid | $14.9M | $17.7M | $31.6M |
| Interest received | $21.0M | $27.7M | $14.2M |
| Recognition of operating lease right-of-use assets and liabilities | $3.1M | $1.3M | $5.2M |
| Exercise of options | $122.0K | $49.0K | $20.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led InMode Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerMoshe Mizrahy Mar 18, 2026 to now11
- PresidentMichael Howard Dennison Mar 18, 2026 to now12
- Chief financial officerYair Malca Mar 18, 2026 to May 26, 202613
- Chief financial officerItzkovich Moshe May 26, 2026 to now14
Board members and other officers (7)
- Chief Technology OfficerMichael Kreindel Mar 18, 2026 to now15
- Board memberHadar Ron Mar 18, 2026 to now16
- Board memberMichael J. Anghel Mar 18, 2026 to now17
- Board memberMichael Kreindel Mar 18, 2026 to now15
- Board memberMoshe Mizrahy Mar 18, 2026 to now11
- Board memberNadav Kenneth Mar 18, 2026 to now18
- Board memberShlomo Nass May 26, 2026 to now19
Timeline
- Mar 18, 2026New chief executive Moshe Mizrahy becomes CEO11
Filings
88 filings to the SEC since October 2021: 5 annual reports, 13 insider forms, 11 large holders, 59 other. The latest 20:
- Sep 16, 20266-K EDGAR
- Aug 11, 20266-K EDGAR
- Aug 5, 2026SCHEDULE 13D/A EDGAR
- Aug 5, 20264 EDGAR
- Aug 5, 20266-K EDGAR
- Aug 3, 20266-K EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 20, 20266-K EDGAR
- Jul 13, 20266-K EDGAR
- Jul 10, 20266-K EDGAR
- Jun 25, 20266-K EDGAR
- Jun 24, 2026SCHEDULE 13D/A EDGAR
- Jun 24, 20266-K EDGAR
- Jun 18, 20266-K EDGAR
- May 26, 20263 EDGAR
- May 26, 20263 EDGAR
- May 20, 20266-K EDGAR
- May 6, 20266-K EDGAR
The 88 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Moshe MizrahySCHEDULE 13D/A, 6 filings Jan 16, 2025 to Aug 5, 202620
- Michael KreindelSCHEDULE 13D, 1 filing Apr 9, 202621
- BoomerangFX International SRLSC 13G/A, 3 filings Feb 14, 2022 to Feb 13, 202422
Members of Congress who traded it
2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Feb 24, 2020 | Tom Rice, House | Sale | $1,001 - $15,000 | +159.7% | Report |
| Feb 24, 2020 | Tom Rice, House | Sale | $1,001 - $15,000 | +159.7% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARInMode Ltd. filings on SEC EDGAR
- 2SEC EDGARInMode Ltd. 10-K for fiscal 2025
- 3SEC EDGARInMode Ltd. filings on SEC EDGAR
- 4
- 5SEC EDGARInMode Ltd. 10-K for fiscal 2018
- 6SEC EDGARInMode Ltd. 10-K for fiscal 2019
- 7SEC EDGARInMode Ltd. 10-K for fiscal 2020
- 8SEC EDGARInMode Ltd. 10-K for fiscal 2021
- 9SEC EDGARInMode Ltd. 10-K for fiscal 2022
- 10SEC EDGARInMode Ltd. 10-K for fiscal 2018
- 11
- 12SEC EDGARMichael Howard Dennison, President
- 13SEC EDGARYair Malca, Chief financial officer
- 14
- 15
- 16SEC EDGARHadar Ron, Board member
- 17SEC EDGARMichael J. Anghel, Board member
- 18SEC EDGARNadav Kenneth, Board member
- 19SEC EDGARShlomo Nass, Board member
- 20
- 21
- 22